Skip to main content
. 2018 Jun 1;32(6):241–250. doi: 10.1089/apc.2017.0303

Table 1.

Participant Characteristics

  Total (N = 77)
Gender, n (%)
 Male 49 (64)
 Female 26 (34)
 Transgender male to female 2 (3)
Race/ethnicity, n (%)
 White non-Hispanic 26 (34)
 Black non-Hispanic 38 (49)
 Hispanic 6 (8)
 Asian 1 (1)
 Multiple races 5 (6)
 Refused 1 (1)
Income compared with federal poverty level (FPL), n (%)
 0% ≤ FPL <50% 45 (58)
 50% ≤ FPL <100% 11 (14)
 100% ≤ FPL <150% 12 (16)
 150% ≤ FPL <200% 5 (6)
 200% ≤ FPL 4 (5)
Risk factor, n (%)
 Heterosexual 37 (48)
 Injection drug use (IDU) 3 (4)
 IDU/MSM 2 (3)
 Men who have sex with men (MSM) 31 (40)
 Transgender male to female 2 (3)
 Do not know/missing 2 (3)
Level of education, n (%)
 ≤6 Years 1 (1)
 7–11 Years 14 (18)
 High school graduate 27 (35)
 General equivalency diploma (GED) 8 (10)
 Community college 2 (3)
 Trade or technical school 4 (5)
 Some college 15 (19)
 College graduate 6 (8)
Baseline HRSA-1, n (%)
 No 38 (49)
 Yes 39 (51)
Baseline visit constancy, n (%)
 1 42 (55)
 2 18 (23)
 3 17 (22)
Distance in miles from clinic, mean (SD) 37 (37)
Travel time in minutes to Clinic, mean (SD) 47 (31)
Housing status, n (%)
 Own place, room, apartment, or house 57 (74)
 Temporarily doubled up with others 15 (19)
 Temporary, transitional housing program 1 (1)
 In shelter for homeless people 2 (3)
 On the street or outside 1 (1)
 Someplace else 1 (1)
Time in months living in present home situation, mean (SD) 41 (74)
Enrollment characteristics, mean (SD)
 Months from HIV diagnosis to enrollment 60 (76)
 Age in years at enrollment 36 (12)
Clinical characteristics, mean (SD)
 Baseline CD4+ 522 (373)
 Baseline VL 23,682 (60820)
 Baseline log10(1+VL) 2.46 (1.79)
 Baseline appointment Adherence 85 (23)